Update on Uric Acid and the Kidney.
Giana Kristy Ramos1,2, David S Goldfarb3,4
1Nephrology Division, NYU Langone Health, New York, NY, USA.
Current Rheumatology Reports
|April 14, 2022
Summary
Recent research indicates that while high uric acid can cause kidney stones, lowering it doesn't slow chronic kidney disease (CKD) or protect against Parkinson's. Higher gout medication doses show promise for CKD management.
Area of Science:
- Nephrology
- Urology
- Endocrinology
Background:
- Elevated serum uric acid is linked to chronic kidney disease (CKD) progression.
- Previous studies on slowing CKD progression with uric acid-lowering medications yielded mixed results.
- The role of uric acid in neuroprotection and its association with kidney stones requires further investigation.
Purpose of the Study:
- To review recent findings on uric acid's association with kidney health, including kidney stones, CKD, and gout management.
- To evaluate the impact of manipulating uric acid levels on CKD progression and neuroprotection.
- To assess the safety and efficacy of higher-dose urate-lowering therapies.
Main Methods:
- Review of recent clinical studies and trials (e.g., PERL, CKD-FIX, SURE-PD3, STOP-GOUT).
- Analysis of factors contributing to uric acid stone formation, including urinary pH.
- Examination of the effects of medications like allopurinol, febuxostat, and thiazolidinediones.
Main Results:
- Studies did not confirm that allopurinol slows CKD progression.
- Increasing uric acid did not slow Parkinson's disease progression; however, high urinary uric acid caused uric acid stones, linked to low urinary pH.
- Higher doses of allopurinol and febuxostat showed a lack of significant adverse events in gout patients with varying kidney function.
Conclusions:
- Current evidence does not support lowering serum uric acid to slow CKD progression or provide neuroprotection.
- Uric acid stones are primarily associated with low urinary pH, not necessarily high serum uric acid levels.
- Higher urate-lowering medication dosages may be feasible and warrant further investigation for potential CKD benefits.
Related Concept Videos
Factors Affecting Renal Clearance: Renal Impairment
175
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
175
Urinary Tract Calculi III: Medical Management
42
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
42
Serum Studies: Renal Function Tests
82
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
82
Urinary Tract Calculi I: Introduction
63
Renal calculi, or kidney stones, are solid deposits of minerals and salts formed inside the kidneys. In medical terminology, "calculus" refers to the stone itself, while "lithiasis" describes the process of stone formation. Depending on their location within the urinary system, these stones may be classified as either urolithiasis, when situated within the urinary tract, or nephrolithiasis, when located within the kidneys. Each term signifies the specific impact of the stone.Predisposition...
63
Introduction to Urinary System
4.5K
The urinary system consists of two kidneys, two ureters, the urinary bladder, and the urethra.
The kidneys are bean-shaped organs located in the retroperitoneal space, on either side of the vertebral column, between the T12 and L3 vertebrae. They are partially protected by the rib cage and surrounded by perirenal fat, which provides cushioning. They are responsible for urine formation and play critical roles in regulating blood pressure, electrolyte levels, and hormone production. The ureters...
The kidneys are bean-shaped organs located in the retroperitoneal space, on either side of the vertebral column, between the T12 and L3 vertebrae. They are partially protected by the rib cage and surrounded by perirenal fat, which provides cushioning. They are responsible for urine formation and play critical roles in regulating blood pressure, electrolyte levels, and hormone production. The ureters...
4.5K
Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa
311
The pH of urine, the drug's pKa, and the urine flow rate are vital parameters for drug reabsorption and excretion. Urinary pH varies between 4.6 and 8.0 and is influenced by diet, drug intake, and the patient's pathophysiology. It affects a drug's ionization state and reabsorption. For instance, carbohydrate-rich food produces alkaline urine promoting drug excretion, while proteins and certain medications like ascorbic acid lead to acidic urine enhancing reabsorption.
The pKa of a...
The pKa of a...
311
![Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F61682.jpg&w=3840&q=50)

